Treatment of lymphatic malformations with ok-432 (picibanil): Review of the literature

Journal of Craniofacial Surgery

Volumn 20, Issue 4, 2009, Pages 1159-1162

  Poldervaart, Michelle T ^a   Breugem, Corstiaan C ^a   Speleman, Lucienne ^a   Pasmans, Suzanne ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Cystic hygroma; Lymphangioma; Lymphatic malformation; OK 432; Picibanil; Sclerotherapy

Indexed keywords

PICIBANIL;

ARTICLE; CLINICAL TRIAL; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG FEVER; FOLLOW UP; HUMAN; INFLAMMATION; LETHARGY; LYMPHATIC MALFORMATION; LYMPHATIC SYSTEM DISEASE; PRIORITY JOURNAL; RECURRENCE RISK; RISK ASSESSMENT; SCLEROTHERAPY;

CYSTS; HUMANS; LYMPHATIC ABNORMALITIES; PICIBANIL; SCLEROSING SOLUTIONS; SCLEROTHERAPY;

EID: 68949196101     PISSN: 10492275     EISSN: None     Source Type: Journal    
DOI: 10.1097/SCS.0b013e3181abb249     Document Type: Article

References (32)

1. Zadvinskis DP, Benson MT, Kerr HH, et al. Congenital malformations of the cervico-thoracic lymphatic system: embryology and pathogenesis. Radiographics 1992;12:1175-1189
2. Ninh TN, Ninh TX. Cystic hygroma in children: a report of 126 cases. J Pediatr Surg 1974;9:191-195
3. McGill TJ, Mulliken JB. Vascular anomalies of the head and neck. Cummings CW, Kriederickson JM, Harker LA, et al, eds. London: Mosby 1993;333-346
4. Wittekindt C, Michel O, Streppel M, et al. Lymphatic malformations of the head and neck: introduction of a disease score for children (CDS). Int J Pediatr Otorhinolaryngol 2006;70:1205-1212
5. de Serres LM, Sie KC, Richardson MA. Lymphatic malformations of the head and neck. A proposal for staging. Arch Otolaryngol Head Neck Surg 1995;121:577-582
6. Sichel JY, Udassin R, Gozal D, et al. OK-432 therapy for cervical lymphangioma. Laryngoscope 2004;114:1805-1809
7. Williams WT, Cole RR. Lymphatic malformation presenting as congenital stridor. Int J Pediatr Otorhinolaryngol 1993;26:185-191
8. Orvidas U, Kaspenbauer JL. Pediatric lymphangiomas of the head and neck. Ann Otol Rhinol Laryngol 2000;109:411-421
9. Smith RJH. Lymphatic malformations. Lymphat Res Biol 2004;2:25-31
10. McGill TJI, Forsen JW Jr, Mulliken JB. Hemangioma and vascular anomalies of the head and neck. Otolaryngol Head Neck Surg 1998;29:784-785
11. Burrows PE, Mason KP. Percutaneous treatment of low flow vascular malformations. J Vasc Interv Radiol 2004;15:431-445
12. Ishida N, Hoshino T. A streptococcal preparation as a potent biological response modifier OK-432. 2nd ed. Amsterdam, the Netherlands: Excerpta Medica, 1985:1-5, 26-47, 60-62
13. Fujino A, Moriya Y, Morakiwa Y, et al. A role of cytokines in OK-432 injection therapy for cystic lymphangioma: an approach to the mechanism. J Pediatr Surg 2003;38:1806-1809
14. Luzatto C, Midrio P, Tchaprassian Z, et al. Sclerosing treatment of lymphangiomas with OK-432. Arch Dis Child 2007;82:316-318
15. Ogita S, Tsuto T, Tokiwa T, et al. OK-432 therapy for unresectable lymphangiomas in children. J Pediatr Surg 1991;26:263-270
16. Giguere CM, Bauman NM, Sato Y, et al. Treatment of lymphangiomas with OK-432 (picibanil) sclerotherapy. Arch Otolaryngol Head Neck Surg 2002;128:1137-1144
17. Luzatto C, Lo Piccolo R, Fascetti Leon F, et al. Further experience with OK-432 for lymphangiomas. Pediatr Surg Int 2005;21:969-972
18. Claesson G, Kuylenstierna R. Int J Otolaryngol. 2002;65:1-6
19. Sung MW, Lee DW, Kim DY, et al. Sclerotherapy with picibanil (OK-432) for congenital lymphatic malformation in the head and neck. Laryngoscope 2001;111:1430-1433
20. Banieghbal B, Davies MRQ. Guidelines for the successful treatment of lymphangioma with OK-432. Eur J Pediatr Surg 2003;13:103-107
21. Rautio R, Keski-Nisula L, Laranne J, et al. Treatment of lymphangiomas with OK-432 (picibanil). Cardiovasc Intervent Radiol 2003;26:31-36
22. Laranne J, Keski-Nisula L, Rautio R, et al. OK-432 (picibanil) therapy for lymphangiomas in children. Eur Arch Otorhinolaryngol 2002; 259:274-278
23. Hall N, Louis FJ. An uncommon complication of cystic hygroma injection with OK-432. Aust J Otolaryngol 2003;6:97-99
24. Ogita S, Tsuto T, Nakamura K, et al. OK-432 therapy in 64 patients with lymphangioma. J Pediatr Surg 1994;29:784-485
25. Greinwald JH, Burke DK, Sato Y, et al. Treatment of lymphangiomas in children: an update of picibanil (OK-432) sclerotherapy. Otolaryngol Head Neck Surg 1999;121:381-387
26. Dubois J, Garel L, Albela A, et al. Lymphangiomas in children: percutaneous sclerotherapy with an alcoholic solution of zein. Radiology 1997;204:651
27. Orrford J. Bleomycine therapy for cystic hygroma. J Pediatr Surg 1995;30:1282-1287
28. Sung MW, Lee DW, Kim DY, et al. Sclerotherapy with picibanil (OK-432) for congenital lymphatic malformation in the head and neck. Laryngoscope 2001;111:1430-1433
29. Peters DA, Courtemanche DJ, Heran MKS, et al. Treatment of cystic lymphatic vascular malformations with OK-432 sclerotherapy. Plast Reconstr Surg 2006;118:1441-1446
30. Schmidt B, Schimpl G, Hollwarth ME. OK-432 therapy of lymphangiomas in children. Eur J Pedriatr 1996;155:649-652
31. Brewis C, Pracy JP, Albert DM. Treatment of lymphangiomas of the head and neck in children by intralesional injection of OK-432 (picibanil). Clin Otolaryngol 2000;25:130-134
32. Kennedy TL, Whitaker M, Pelliteri P, et al. Cystic hygroma/lymphangioma: a rational approach to management. Laryngoscope 2001;111:1929-1937